retatrutide triple agonist weight loss trial for loss: Study shows 30% body weight Lilly's retatrutide phase 3 results:

Cardio guidance Daily steps: 7,000-10,000 steps for general health, NEAT, and gradual fat loss support

For more information, contact us or book an appointment

The ideal candidate is someone who has a meaningful fat-loss goal, defined as 20 lbs or more to reduce, who is also concerned about how skin quality and connective tissue integrity will hold up through that process

If youre currently taking one or considering starting, speak to your GP or another healthcare professional for personalised advice

Use, Access and Affordability of GLP-1 Drugs KFFs latest Health Tracking Poll provides an update to last years poll measuring public use of GLP-1 agonists, a group of prescription drugs including name brands like Ozempic, Wegovy, Zepbound and others commonly prescribed for weight loss, the treatment of diabetes, reduction of cardiovascular disease risk, and some other chronic conditions 1

This article examines the evidence for natural compounds that may influence GLP-1 and GIP activity, their safety considerations, and when to consult your GP about metabolic health concerns